Hana Pharm Co Ltd
KRX:293480
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10 150
14 380
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Hana Pharm Co Ltd
| Current Assets | 100.8B |
| Cash & Short-Term Investments | 5.2B |
| Receivables | 43B |
| Other Current Assets | 52.7B |
| Non-Current Assets | 250.2B |
| Long-Term Investments | 69.8B |
| PP&E | 158.6B |
| Intangibles | 15.5B |
| Other Non-Current Assets | 6.4B |
| Current Liabilities | 32.3B |
| Accounts Payable | 5.5B |
| Accrued Liabilities | 3B |
| Short-Term Debt | 2B |
| Other Current Liabilities | 21.9B |
| Non-Current Liabilities | 37.7B |
| Long-Term Debt | 24.9B |
| Other Non-Current Liabilities | 12.8B |
Balance Sheet
Hana Pharm Co Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
568
|
1 389
|
12 941
|
16 988
|
14 985
|
20 546
|
6 615
|
12 548
|
|
| Cash |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
568
|
1 388
|
12 940
|
16 987
|
14 985
|
20 546
|
6 615
|
12 548
|
|
| Short-Term Investments |
3 098
|
1 770
|
3 550
|
89 323
|
74 425
|
52 830
|
50 251
|
5 034
|
|
| Total Receivables |
34 853
|
38 633
|
43 060
|
43 034
|
42 427
|
43 511
|
42 780
|
44 306
|
|
| Accounts Receivables |
29 626
|
34 410
|
37 554
|
36 658
|
36 477
|
37 778
|
35 382
|
35 724
|
|
| Other Receivables |
5 227
|
4 223
|
5 506
|
6 376
|
5 950
|
5 732
|
7 398
|
8 582
|
|
| Inventory |
14 386
|
18 027
|
19 270
|
22 006
|
26 886
|
30 730
|
40 693
|
41 404
|
|
| Other Current Assets |
84
|
658
|
578
|
220
|
166
|
178
|
116
|
235
|
|
| Total Current Assets |
52 989
|
60 476
|
79 398
|
171 572
|
158 888
|
147 794
|
140 455
|
103 527
|
|
| PP&E Net |
40 609
|
49 664
|
46 653
|
46 314
|
78 275
|
93 074
|
122 399
|
151 868
|
|
| PP&E Gross |
0
|
49 664
|
46 653
|
46 314
|
78 275
|
93 074
|
122 399
|
151 868
|
|
| Accumulated Depreciation |
0
|
35 949
|
38 795
|
42 510
|
45 276
|
50 073
|
52 395
|
55 473
|
|
| Intangible Assets |
2 167
|
1 986
|
3 384
|
5 319
|
5 480
|
7 975
|
12 837
|
11 990
|
|
| Long-Term Investments |
778
|
1 152
|
9 443
|
16 283
|
16 229
|
20 933
|
24 182
|
72 104
|
|
| Other Long-Term Assets |
897
|
1 315
|
2 673
|
2 892
|
4 162
|
6 804
|
3 624
|
6 476
|
|
| Total Assets |
97 440
N/A
|
114 592
+18%
|
141 551
+24%
|
242 380
+71%
|
263 034
+9%
|
276 579
+5%
|
303 497
+10%
|
345 965
+14%
|
|
| Liabilities | |||||||||
| Accounts Payable |
6 332
|
6 921
|
7 352
|
6 330
|
6 938
|
6 032
|
6 678
|
8 064
|
|
| Accrued Liabilities |
2 195
|
2 102
|
2 303
|
2 598
|
2 613
|
2 926
|
1 723
|
2 726
|
|
| Short-Term Debt |
7 691
|
1 751
|
1 730
|
469
|
1 064
|
1 000
|
8 397
|
10 445
|
|
| Current Portion of Long-Term Debt |
5 191
|
8 028
|
21 102
|
2 612
|
2 618
|
2 603
|
1 148
|
1 523
|
|
| Other Current Liabilities |
12 657
|
15 293
|
16 226
|
17 619
|
20 424
|
21 677
|
22 899
|
21 947
|
|
| Total Current Liabilities |
34 066
|
34 095
|
48 713
|
29 628
|
33 658
|
34 237
|
40 845
|
44 704
|
|
| Long-Term Debt |
26 389
|
21 155
|
6 214
|
1 568
|
1 773
|
897
|
1 230
|
22 132
|
|
| Deferred Income Tax |
1 279
|
1 464
|
1 213
|
457
|
0
|
314
|
504
|
588
|
|
| Minority Interest |
0
|
0
|
358
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1 977
|
2 394
|
4 113
|
5 341
|
7 272
|
8 750
|
9 018
|
10 143
|
|
| Total Liabilities |
63 711
N/A
|
59 108
-7%
|
60 611
+3%
|
36 994
-39%
|
42 702
+15%
|
44 198
+4%
|
51 596
+17%
|
77 568
+50%
|
|
| Equity | |||||||||
| Common Stock |
3 706
|
4 872
|
6 059
|
8 100
|
8 100
|
8 100
|
8 886
|
8 886
|
|
| Retained Earnings |
28 211
|
45 958
|
69 506
|
92 398
|
115 697
|
123 421
|
143 064
|
159 224
|
|
| Additional Paid In Capital |
1 800
|
2 495
|
3 200
|
105 243
|
105 246
|
105 246
|
104 459
|
104 459
|
|
| Unrealized Security Profit/Loss |
11
|
2 160
|
2 174
|
2 142
|
2 142
|
6 467
|
6 409
|
6 745
|
|
| Treasury Stock |
0
|
0
|
0
|
2 497
|
10 853
|
10 853
|
10 918
|
10 918
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
33 729
N/A
|
55 485
+65%
|
80 940
+46%
|
205 386
+154%
|
220 332
+7%
|
232 382
+5%
|
251 901
+8%
|
268 397
+7%
|
|
| Total Liabilities & Equity |
97 440
N/A
|
114 592
+18%
|
141 551
+24%
|
242 380
+71%
|
263 034
+9%
|
276 579
+5%
|
303 497
+10%
|
345 965
+14%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
8
|
11
|
13
|
18
|
17
|
17
|
17
|
17
|
|
You don't have any saved screeners yet
